» Articles » PMID: 23835342

Long-term Effects of Bariatric Surgery on Meal Disposal and β-cell Function in Diabetic and Nondiabetic Patients

Overview
Journal Diabetes
Specialty Endocrinology
Date 2013 Jul 10
PMID 23835342
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Gastric bypass surgery leads to marked improvements in glucose tolerance and insulin sensitivity in obese type 2 diabetes (T2D); the impact on glucose fluxes in response to a physiological stimulus, such as a mixed meal test (MTT), has not been determined. We administered an MTT to 12 obese T2D patients and 15 obese nondiabetic (ND) subjects before and 1 year after surgery (10 T2D and 11 ND) using the double-tracer technique and modeling of β-cell function. In both groups postsurgery, tracer-derived appearance of oral glucose was biphasic, a rapid increase followed by a sharp drop, a pattern that was mirrored by postprandial glucose levels and insulin secretion. In diabetic patients, surgery lowered fasting and postprandial glucose levels, peripheral insulin sensitivity increased in proportion to weight loss (~30%), and β-cell glucose sensitivity doubled but did not normalize (compared with 21 nonsurgical obese and lean controls). Endogenous glucose production, however, was less suppressed during the MMT as the combined result of a relative hyperglucagonemia and the rapid fall in plasma glucose and insulin levels. We conclude that in T2D, bypass surgery changes the postprandial response to a dumping-like pattern and improves glucose tolerance, β-cell function, and peripheral insulin sensitivity but worsens endogenous glucose output in response to a physiological stimulus.

Citing Articles

Elevations in plasma glucagon are associated with reduced insulin clearance after ingestion of a mixed-macronutrient meal in people with and without type 2 diabetes.

Smith K, Taylor G, Peeters W, Walker M, Perazzolo S, Atabaki-Pasdar N Diabetologia. 2024; 67(11):2555-2567.

PMID: 39138690 PMC: 11519192. DOI: 10.1007/s00125-024-06249-7.


Differential effect of endogenous glucagon-like peptide-1 on prandial glucose counterregulatory response to hypoglycaemia in humans with and without bariatric surgery.

Honka H, Gastaldelli A, Pezzica S, Peterson R, DeFronzo R, Salehi M Diabetes Obes Metab. 2024; 26(6):2476-2486.

PMID: 38558527 PMC: 11078606. DOI: 10.1111/dom.15570.


Vagal activation alters prandial bile acid composition and glycemia in patients with hypoglycemia after Roux-en-Y gastric bypass surgery.

Honka H, Bhattacharjee J, Zadeh M, Kohli R, Gastaldelli A, Salehi M Neurogastroenterol Motil. 2024; 36(5):e14763.

PMID: 38342974 PMC: 11043014. DOI: 10.1111/nmo.14763.


Differential effect of gastric bypass versus sleeve gastrectomy on insulinotropic action of endogenous incretins.

Salehi M, Peterson R, Tripathy D, Pezzica S, DeFronzo R, Gastaldelli A Obesity (Silver Spring). 2023; 31(11):2774-2785.

PMID: 37853989 PMC: 10593483. DOI: 10.1002/oby.23872.


O304 ameliorates hyperglycemia in mice by dually promoting muscle glucose effectiveness and preserving β-cell function.

Norlin S, Axelsson J, Ericsson M, Edlund H Commun Biol. 2023; 6(1):877.

PMID: 37626210 PMC: 10457357. DOI: 10.1038/s42003-023-05255-6.


References
1.
Unger R, Cherrington A . Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. J Clin Invest. 2012; 122(1):4-12. PMC: 3248306. DOI: 10.1172/JCI60016. View

2.
Laferrere B, Teixeira J, Mcginty J, Tran H, Egger J, Colarusso A . Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab. 2008; 93(7):2479-85. PMC: 2453054. DOI: 10.1210/jc.2007-2851. View

3.
Falken Y, Hellstrom P, Holst J, Naslund E . Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides. J Clin Endocrinol Metab. 2011; 96(7):2227-35. DOI: 10.1210/jc.2010-2876. View

4.
Meier J, Nauck M, Pott A, Heinze K, Goetze O, Bulut K . Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans. Gastroenterology. 2006; 130(1):44-54. DOI: 10.1053/j.gastro.2005.10.004. View

5.
Carlsson L, Peltonen M, Ahlin S, Anveden A, Bouchard C, Carlsson B . Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med. 2012; 367(8):695-704. DOI: 10.1056/NEJMoa1112082. View